Medicine non-adherence in kidney transplantation

Journal of Renal Care

Volumn 40, Issue 2, 2014, Pages 107-116

  Williams, Allison Fiona ^a   Manias, Elizabeth ^b   Gaskin, Cadeyrn J ^a   Crawford, Kimberley ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Immunosuppression; Nursing, Self management self care, Transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ATTITUDE TO HEALTH; COOPERATION; GRAFT REJECTION; HUMAN; INTERDISCIPLINARY COMMUNICATION; KIDNEY TRANSPLANTATION; MEDICATION COMPLIANCE; NURSE PATIENT RELATIONSHIP; NURSING; PSYCHOLOGY;

ATTITUDE TO HEALTH; COOPERATIVE BEHAVIOR; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERDISCIPLINARY COMMUNICATION; KIDNEY TRANSPLANTATION; MEDICATION ADHERENCE; NURSE-PATIENT RELATIONS;

EID: 84901601037     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/jorc.12063     Document Type: Article

References (59)

1. Berg K.M. & Arnsten J.H. (2006). Practical and conceptual challenges in measuring antiretroviral adherence. Journal of Acquired Immune Deficiency Syndromes 43, S79-S87.
2. Butler J.A., Roderick P., Mullee M. et al. (2004). Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation 77, 769-776.
3. Cass A., Chadban S., Gallagher M. et al. (2006). The economic impact of end stage kidney disease in Australia: projections to 2020. Kidney Health Australia.
4. Chadban S.J., Briganti E.M., Kerr P.G. et al. (2003). Prevalence of kidney damage in Australian adults: the AusDiab Kidney Study. Journal of the American Society of Nephrology 14, S131-S138.
5. Chisholm M.A. (2002). Enhancing transplant patients' adherence to medication therapy. Clinical Transplantation 16, 30-38.
6. Chisholm M.A., Vollenweider L.J., Mulloy L.L. et al. (2000). Renal transplant patient compliance with free immunosuppressive medications. Transplantation 70, 1240-1244.
7. Chisholm M.A., Mulloy L.L., Jagadeesan M. et al. (2001). Impact of clinical pharmacy services on renal transplant patients' compliance with immuno suppressive medications. Clinical Transplantation 15, 330-336.
8. Chisholm-Burns M.A., Spivey C.A., Graff Zivin J. et al. (2013). Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial. Am J Transplant 9, 2364-2373.
9. Clayton P., Campbell S., Hurst K. et al. (2011). Transplantation Australian & New Zealand Dialysis & Transplant Registry Report. Adelaide, South Australia
10. Coresh J., Selvin E., Stevens L.A. et al. (2007). Prevalence of chronic kidney disease in the United States. Journal of the American Medical Association 298, 2038-2047.
11. Couzi L., Moulin B., Morin M.P. et al. (2013). Factors predictive of medication nonadherence after renal transplantation: a French observational study. Transplantation 95, 326-332.
12. Cramer J.A. (1995). Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 49, 321-327.
13. De Bleser L., Matteson M., Dobbels F. et al. (2009). Interventions to improve medication-adherence after transplantation: a systematic review. Transplant International 22, 780-797.
14. De Geest S., Abraham I., Moons P. et al. (1998). Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients. Journal of Heart and Lung Transplantation 17, 854-863.
15. De Geest S., Schafer-Keller P., Denhaerynck K. et al. (2006). Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clinical Transplantation 20, 359-368.
16. Dejean N.B., Rostaing L., Mestre M.L. et al. (2004). Educational program to reduce noncompliance after renal transplantation. American Journal of Transplantation 4, 520-521.
17. Denhaerynck K., Dobbels F., Cleemput I. et al. (2005). Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transplant International 18, 1121-1133.
18. Denhaerynck K., Desmyttere A., Dobbels F. et al. (2006). Nonadherence with immunosuppressive drugs: U.S. compared with European kidney transplant recipients. Progress in Transplantation 16, 206-214.
19. Denhaerynck K., Schafer-Keller P., Young J. et al. (2008). Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Medical Research Methodology 8, 5.
20. Eknoyan G., Lameire N., Barsoum R. et al. (2004). The burden of kidney disease: improving global outcomes. Kidney International 66, 1310-1314.
21. Farmer K.C. (1999). Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics 21, 1074-1090.
22. Fine R.N., Becker Y., De Geest S. et al. (2009). Nonadherence consensus conference summary report. American Journal of Transplantation 9, 35-41.
23. Fraser S.D., Roderick P.J., Casey M. et al. (2013). Prevalence and associations of limited health literacy in chronic kidney disease: a systematic review. Nephrology Dialysis Transplantation 28, 129-137.
24. Gondos A., Dohler B., Brenner H. et al. (2013). Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation 95, 267-274.
25. Gordon E.J., Gallant M., Sehgal A.R. et al. (2009). Medication-taking among adult renal transplant recipients: barriers and strategies. Transplant International 22, 534-545.
26. Hardstaff R., Green K. & Talbot D. (2003). Measurement of compliance posttransplantation-The results of a 12-month study using electronic monitoring. Transplantation Proceedings 35, 796-797.
27. Haynes R.B., Ackloo E., Sahota N. et al. (2008). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews (2). Art. No.: CD000011, doi: 10.1002/14651858.CD000011.pub3
28. Howard K., Salkeld G., White S. et al. (2009). The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology 14, 123-132.
29. Khan S. & Amedia C.A. (2008). Economic burden of chronic kidney disease. Journal of Evaluation in Clinical Practice 14, 422-434.
30. Lee J.K., Grace K.A. & Taylor A.J. (2006). Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol-a randomized controlled trial. Journal of the American Medical Association 296, 2563-2571.
31. Lennerling A. & Forsberg A. (2012). Self-reported non-adherence and beliefs about medication in a Swedish kidney transplant population. Open Nursing Journal 6, 41-46.
32. Mcdonald S. (2011). Transplant waiting list. Australian & New Zealand Dialysis & Transplant Registry Report. Adelaide, South Australia.
33. Mcdonald S. & Hurst K. (2011). Thirty Fourth Annual Report. Australian & New Zealand Dialysis & Transplant Registry Report. Adelaide, South Australia.
34. Mcdonald S., Excell L. & Livingston B. (2009). Transplantation. ANZDATA Registry Report. Adelaide, South Australia.
35. Meier-Kriesche H.U., Schold J.D. & Kaplan B. (2004a). Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? American Journal of Transplantation 4, 1289-1295.
36. Meier-Kriesche H.U., Schold J.D., Srinivas T.R. et al. (2004b). Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. American Journal of Transplantation 4, 378-383.
37. Morrissey P.E., Flynn M.L. & Lin S. (2007). Medication noncompliance and its implications in transplant recipients. Drugs 67, 1463-1481.
38. Nevins T.E. & Thomas W. (2009). Quantitative patterns of azathioprine adherence after renal transplantation. Transplantation 87, 711-718.
39. Ojo A.O., Morales J.M., Gonzalez-Molina M. et al. (2013). Comparison of the long-term outcomes of kidney transplantation: USA versus Spain. Nephrology Dialysis Transplantation 28, 213-220.
40. Orr A., Orr D., Willis S. et al. (2007). Patient perceptions of factors influencing adherence to medication following kidney transplant. Psychology Health Medicine 12, 509-517.
41. Pinsky B.W., Takemoto S.K., Lentine K.L. et al. (2009). Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. American Journal of Transplantation 9, 2597-2606.
42. Ponticelli C. & Graziani G. (2012). Education and counseling of renal transplant recipients. Journal of Nephrology 25, 879-889.
43. Ponticelli C., Colombo D., Novara M. et al. (2010). Gastrointestinal symptoms impair quality of life in Italian renal transplant recipients but are under-recognized by physicians. Transplant International 23, 1126-1134.
44. Raiz L.R., Kilty K.M., Henry M.L. et al. (1999). Medication compliance following renal transplantation. Transplantation 68, 51-55.
45. Ruppar T.M. & Russell C.L. (2009). Medication adherence in successful kidney transplant recipients. Progress in Transplantation 19, 167-172.
46. Russell C.L. (2010). A clinical nurse specialist-led intervention to enhance medication adherence using the plan-do-check-act cycle for continuous self-improvement. Clinical Nurse Specialist 24, 69-75.
47. Russell C.L. & Ashbaugh C. (2004). The experience of immunosuppressive medication noncompliance: a case study. Dialysis & Transplantation 33, 610-623.
48. Russell C.L., Kilburn E., Conn V.S. et al. (2003). Medication-taking beliefs of adult renal transplant recipients. Clinical Nurse Specialist 17, 200-208.
49. Russell C.L., Owens S., Hamburger K.Q. et al. (2009). Medication adherence and older renal transplant patients' perceptions of electronic medication monitoring. Journal of Gerontological Nursing 35, 17-21.
50. Russell C., Conn V., Ashbaugh C. et al. (2011). Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients. Clinical Transplantation 25, 864-870.
51. Sabaté E. (2003). Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization.
52. Steiner J.F. & Prochazka A.V. (1997). The assessment of refill compliance using pharmacy records: methods, validity, and applications. Journal of Clinical Epidemiology 50, 105-116.
53. Tong A., Sainsbury P., Chadban S. et al. (2009). Patients' experiences and perspectives of living with CKD. American Journal of Kidney Diseases 53, 689-700.
54. Tong A., Howell M., Wong G. et al. (2011). The perspectives of kidney transplant recipients on medicine taking: a systematic review of qualitative studies. Nephrology Dialysis Transplantation 26, 344-354.
55. Vlaminck H., Maes B., Evers G. et al. (2004). Prospective study on late consequences of subclinical non-compliance with immunosuppressive therapy in renal transplant patients. American Journal of Transplantation 4, 1509-1513.
56. Williams A.F., Manias E. & Walker R.G. (2010). The devil is in the detail-a multifactorial intervention to reduce blood pressure in coexisting diabetes and chronic kidney disease: a single blind, randomized controlled trial. BMC Family Practice 11.
57. Williams A., Manias E., Walker R. et al. (2012). A multifactorial intervention to improve blood pressure control in co-existing diabetes and kidney disease: a pilot randomized controlled trial. Journal of Advanced Nursing 68(11), 2515-2525.
58. Williams A.B., Amico K.R., Bova C. et al. (2013). A proposal for quality standards for measuring medication adherence in research. Aids and Behavior 17, 284-297.
59. Wilson I.B., Carter A.E. & Berg K.M. (2009). Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Current HIV/AIDS Reports 6, 177-186.